日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation

对于异基因造血干细胞移植后复发的FLT3野生型急性髓系白血病,索拉非尼联合供体淋巴细胞输注的挽救治疗方案可改善预后。

Jiang, Zhonghui; Zhou, Ya; Bai, Yuxin; Dai, Fang; Fan, Menglin; Zhang, Tian; Nie, Danian; Zeng, Yunxin; Jiang, Yirong; Zhu, Ping; Fan, Zhiping; Xu, Na; Huang, Fen; Lin, Ren; Dai, Min; Xu, Xiaojun; Li, Zhangkun; Jin, Hua; Sun, Jing; Liu, Qifa; Xuan, Li

Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial

地西他滨联合减低强度预处理方案用于接受异基因造血干细胞移植的处于复合完全缓解期的老年急性髓系白血病患者:一项多中心、单臂 II 期试验

Liu, Qifa; Hu, Zhongli; Xu, Na; Jiang, Yirong; Fan, Zhiping; Huang, Fen; Lin, Ren; Jin, Hua; Zeng, Yunxin; He, Hai; Zhu, Ping; Yu, Guopan; Shi, Pengcheng; Sun, Ruijuan; Xu, Xiaojun; Li, Zhangkun; Zhang, Yu; Sun, Jing; Wang, Yu; Xuan, Li

Inhibition of CRM1 reverses hypoxia-driven chemoresistance in acute myeloid leukemia via overcoming HIF-1α-mediated lysosomal sequestration.

抑制 CRM1 可克服 HIF-1α 介导的溶酶体隔离,从而逆转急性髓系白血病中缺氧驱动的化疗耐药性。

Feng Xiaohui, Ding Yuntian, Huang Yuling, Qin Hancheng, Wang Xiaobo, Zeng Yunxin

Aclacinomycin enhances the killing effect of allogeneic NK cells on acute myeloid leukemia cells by inducing immunogenic cell death.

阿克拉霉素通过诱导免疫原性细胞死亡,增强同种异体NK细胞对急性髓系白血病细胞的杀伤作用

Ye Yongbin, Liu Ning, Zeng Yunxin, Guo Ziwen, Wang Xiaobo, Xu Xiaojun

Romiplostim versus Recombinant human thrombopoietin in umbilical cord blood transplantation: a single-center retrospective study

罗米司亭与重组人血小板生成素在脐带血移植中的比较:一项单中心回顾性研究

Ding, Yuntian; Liu, Hengyu; Wang, Yaqun; Deng, Haimei; Sun, Yanfeng; Sun, Tiantian; Wang, Yin; Zeng, Yunxin

Treatment outcomes of zanubrutinib-based regimen in newly diagnosed patients with MYC/BCL2 double-expressor diffuse large B-cell lymphoma: a retrospective multicenter real-world study

一项回顾性多中心真实世界研究:以泽布替尼为基础的治疗方案在初诊MYC/BCL2双表达弥漫性大B细胞淋巴瘤患者中的疗效。

Lu, Bo; Wang, Ying; Jin, Mengdi; Zhang, Jingwei; Xu, Xiaojun; Zeng, Yunxin; Zhao, Lina; Wang, Hua

Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective study

含地西他滨的强化预处理方案与标准清髓性预处理方案治疗KMT2A重排白血病成人患者的疗效比较:一项多中心回顾性研究

Hu, Zhongli; Feng, Zinan; Liu, Shiqi; He, Hai; Dong, Ying; Fan, Zhiping; Li, Yiqing; Huang, Fen; Xu, Na; Liu, Can; Zeng, Yunxin; Zhu, Ping; Lin, Ren; Jin, Hua; Zhang, Xiong; Sun, Ruijuan; Liu, Qifa; Xuan, Li

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease

维多珠单抗联合巴利昔单抗作为类固醇难治性下消化道急性移植物抗宿主病的二线治疗方案

Gao, Zicheng; Fan, Zhiping; Liu, Zhi; Ye, Xu; Zeng, Yunxin; Xuan, Li; Huang, Fen; Lin, Ren; Sun, Jing; Liu, Qifa; Xu, Na

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia

溶酶体靶向葡聚糖-阿霉素纳米药物克服了阿霉素诱导的髓系白血病化疗耐药性

Zeng, Yunxin; Zhang, Xinyu; Lin, Dongjun; Feng, Xiaohui; Liu, Yuye; Fang, Zhengwen; Zhang, Weijian; Chen, Yu; Zhao, Meng; Wu, Jun; Jiang, Linjia

Recent applications and strategies in nanotechnology for lung diseases

纳米技术在肺部疾病治疗中的最新应用和策略

Zhong, Wenhao; Zhang, Xinyu; Zeng, Yunxin; Lin, Dongjun; Wu, Jun